Calls
1
u/More_Advertising_383
Reddit r/wallstreetbets
Win Rate
100.0%
return
+164.4%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 02
$4.33
+164.4%
Author believes SELLAS Life Sciences' GPS phase 3 trial is tracking positively because only 12 events occurred in the past year versus 60 the prior year, implying the drug is extending overall survival. He estimates the win-to-fail ratio has improved and the trial could be halted for efficacy. He plans to hold through phase 3 results and a potential buyout, with SLS009 entering phase 3 this year as a follow-on asset.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/More_Advertising_383 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: SLS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
